Accrelist (SGX:QZG) ROCE % : -8.42% (As of Sep. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Accrelist ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Accrelist's annualized ROCE % for the quarter that ended in Sep. 2024 was -8.42%.

Accrelist ROCE % Historical Data

The historical data trend for Accrelist's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accrelist ROCE % Chart

Accrelist Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

-20.48

-0.37

-25.94

-5.89

-23.16

Accrelist Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
ROCE %	Get a 7-Day Free Trial															-12.01	1.00	-7.14	-38.92	-8.42

Accrelist ROCE % Calculation

Accrelist's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-5.881	/	( ( (60.207 - 31.463)	+	(30.548 - 8.499) )	/ 2 )
	=	-5.881	/	( (28.744	+	22.049)	/ 2 )
	=	-5.881	/	25.3965
	=	-23.16 %

Accrelist's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	-1.828	/	( ( (30.548 - 8.499)	+	(28.511 - 7.134) )	/ 2 )
	=	-1.828	/	( ( 22.049	+	21.377 )	/ 2 )
	=	-1.828	/	21.713
	=	-8.42 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

Accrelist (SGX:QZG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Accrelist ROCE % Related Terms

Thank you for viewing the detailed overview of Accrelist's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Accrelist Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accrelist Ltd (SGX:QZG) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Ubi Crescent, Ubi Techpark, Lobby E No. 03-95, Singapore, SGP, 408564

Website

https://www.accrelist.com.sg

Accrelist Ltd is focused on the distribution of electronics components, plastic injection molding, mold design, and fabrication services. The company's segment comprises a Mechanical business unit (MBU), Aesthetic Medical Services (AMS), and others. Accrelist is focused on maintaining a diversified customer mix and product portfolio for MBU and EBU while continuing to expand upon the medical aesthetic products and services provided to consumers. it generates a vast majority of revenue from the MBU segment.

Accrelist Headlines

No Headlines